MK-677 Side Effects: Safety Signals and Warnings
MK-677 safety concerns are compound-specific. The main listed side effects are Increased appetite, Water retention and edema, and Muscle pain. The main warning signals are Not FDA approved - investigational compound, May impair glucose tolerance and increase insulin resistance with prolonged use, and May increase risk in patients with existing diabetes or prediabetes.
Direct Answer
MK-677 has genuine Phase 2 human data on GH/IGF-1 elevation, body composition, and sleep quality across multiple independent groups - more human evidence than most GH secretagogues in this library. It is oral, which meaningfully differentiates it. The trade-off is water retention, increased appetite, and insulin resistance at sustained doses. For researchers interested in GH axis stimulation with an oral route, MK-677 is the best-evidenced option available.
- Evidence grade
- Level B
- Research status
- Phase 2
- Category
- Growth Hormone
- Best for
- GH/IGF-1 elevation, body composition research, sleep architecture, GH deficiency investigation
Reported Side Effects
- Increased appetite
- Water retention and edema
- Muscle pain
- Joint pain
- Elevated fasting blood glucose
- Lethargy
- Numbness and tingling in extremities
Warnings
- Not FDA approved - investigational compound
- May impair glucose tolerance and increase insulin resistance with prolonged use
- May increase risk in patients with existing diabetes or prediabetes
- Long-term safety data beyond 2 years is limited
- Contraindicated in patients with active malignancy (GH/IGF-1 axis stimulation)
Known or Plausible Interactions
- Insulin and oral hypoglycemics (MK-677 can impair glucose tolerance)
- Corticosteroids (may blunt GH response)
- Other GH secretagogues (additive effects on GH release)
Regulatory Context
Not FDA approved. Not a scheduled substance in most countries. Available as a research chemical. Banned by WADA in competitive sports.
Evidence Snapshot
| Evidence grade | Level B |
|---|---|
| Research status | Phase 2 |
| Best supported outcomes | Growth Hormone and IGF-1 Elevation (Level B), Lean Body Mass (Level B), Sleep Quality (Level B), and Appetite Increase (Level B) |
| Primary citation count | 3 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "MK-677 Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/mk-677-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.